» Articles » PMID: 34504908

Modeling Human Congenital Disorders with Neural Crest Developmental Defects Using Patient-derived Induced Pluripotent Stem Cells

Overview
Journal Regen Ther
Date 2021 Sep 10
PMID 34504908
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The neural crest is said to be the fourth germ layer in addition to the ectoderm, mesoderm and endoderm because of its ability to differentiate into a variety of cells that contribute to the various tissues of the vertebrate body. Neural crest cells (NCCs) can be divided into three functional groups: cranial NCCs, cardiac NCCs and trunk NCCs. Defects related to NCCs can contribute to a broad spectrum of syndromes known as neurocristopathies. Studies on the neural crest have been carried out using animal models such as , chicks, and mice. However, the precise control of human NCC development has not been elucidated in detail due to species differences. Using induced pluripotent stem cell (iPSC) technology, we developed an disease model of neurocristopathy by inducing the differentiation of patient-derived iPSCs into NCCs and/or neural crest derivatives. It is now possible to address complicated questions regarding the pathogenetic mechanisms of neurocristopathies by characterizing cellular biological features and transcriptomes and by transplanting patient-derived NCCs . Here, we provide some examples that elucidate the pathophysiology of neurocristopathies using disease modeling via iPSCs.

Citing Articles

Alternative Balance between Transcriptional and Epigenetic Regulation during Developmental Proliferation of Human Cranial Neural Crest Cells.

Desterke C, Frances R, Monge C, Marchio A, Pineau P, Mata-Garrido J Cells. 2024; 13(19.

PMID: 39404397 PMC: 11476078. DOI: 10.3390/cells13191634.


Clinical and Genetic Correlation in Neurocristopathies: Bridging a Precision Medicine Gap.

Chatzi D, Kyriakoudi S, Dermitzakis I, Manthou M, Meditskou S, Theotokis P J Clin Med. 2024; 13(8).

PMID: 38673496 PMC: 11050951. DOI: 10.3390/jcm13082223.


Fascial Nomenclature: Update 2022.

Bordoni B, Escher A, Tobbi F, Pianese L, Ciardo A, Yamahata J Cureus. 2022; 14(6):e25904.

PMID: 35720786 PMC: 9198288. DOI: 10.7759/cureus.25904.

References
1.
Bundo M, Toyoshima M, Okada Y, Akamatsu W, Ueda J, Nemoto-Miyauchi T . Increased l1 retrotransposition in the neuronal genome in schizophrenia. Neuron. 2014; 81(2):306-13. DOI: 10.1016/j.neuron.2013.10.053. View

2.
Huang X, Saint-Jeannet J . Induction of the neural crest and the opportunities of life on the edge. Dev Biol. 2004; 275(1):1-11. DOI: 10.1016/j.ydbio.2004.07.033. View

3.
Nagashimada M, Ohta H, Li C, Nakao K, Uesaka T, Brunet J . Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression. J Clin Invest. 2012; 122(9):3145-58. PMC: 3428093. DOI: 10.1172/JCI63401. View

4.
Yuan H, Hu H, Chen R, Mu W, Wang L, Li Y . Premigratory neural crest stem cells generate enteric neurons populating the mouse colon and regulating peristalsis in tissue-engineered intestine. Stem Cells Transl Med. 2021; 10(6):922-938. PMC: 8133337. DOI: 10.1002/sctm.20-0469. View

5.
Khan T, Revah O, Gordon A, Yoon S, Krawisz A, Goold C . Neuronal defects in a human cellular model of 22q11.2 deletion syndrome. Nat Med. 2020; 26(12):1888-1898. PMC: 8525897. DOI: 10.1038/s41591-020-1043-9. View